Ovarian dysfunction: androgen excess, drug-induced

PheWeb

E4_ODANDRO_ADVERSE

No definition available.

Endpoint definition

↥

FinnGen phenotype data

356077 individuals

Apply sex-specific rule

Sex only females

198506

Check conditions None

198506

Filter registries

Hospital discharge: ATC codes for adverse effects of drugs ANY

Hospital Discharge: ICD-10 E28.1#

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10

Check minimum number of events None

Include endpoints None

E4_ODANDRO_ADVERSE

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF5

Parent code in ICD-10 E28

Name in latin Hypersecretio androgenorum

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Ovarian dysfunction: androgen excess, drug-induced based on the number of shared cases.

Broader endpoints:

None

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	5	5	-
Unadjusted prevalence (%)	0.00	0.00	-
Mean age at first event (years)	24.58	24.58	-

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_ODANDRO_ADVERSE – Ovarian dysfunction: androgen excess, drug-induced
GWS hits:

Survival analyses between endpoints

↥

Plot

before Ovarian dysfunction: androgen excess, drug-induced
after Ovarian dysfunction: androgen excess, drug-induced

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Ovarian dysfunction: androgen excess, drug-induced

↥

≡ Risteys

R8

R7

R6

R5

R4

R3